ESAB Corp (ESAB) is slightly overvalued and Proto Labs Inc (PRLB) is overvalued.
Both trade above our estimate of their intrinsic value. ESAB is the closer of the two: -13%, against -299% for PRLB.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 8.4% (average of 3 methods) values the shares at $60.32; the price of $68.44 is 13% above that value, and 78% of that value comes from beyond year five.
Leak Score 14/100 on 3 of 12 signals
Discounting its cash flows at 11.4% (average of 3 methods) values the shares at $22.44; the price of $89.46 is 299% above that value, and 68% of that value comes from beyond year five.
Leak Score 0/100 on 2 of 12 signals
| Metric | ESAB | PRLB |
|---|---|---|
| Verdict | Slightly overvalued | Overvalued |
| Price | $68.44 | $89.46 |
| Intrinsic value | $60.32 | $22.44 |
| Margin of safety | -13% | -299% |
| Leak Score | 14/100 (3/12) | 0/100 (2/12) |
| Market cap | $4.3B | $2.1B |
| Revenue growth, 5 years | 7.8% | 4.2% |
| Operating margin | 14.2% | 7.3% |
| Net margin | 5.7% | 5.4% |
| Return on equity | 8.6% | 4.5% |
| Debt to equity | 1.00 | 0.00 |
| P/E | 24.6x | 71.3x |
| Forward P/E | 10.7x | 37.5x |
| P/B | 1.8x | 3.1x |
| Dividend yield | 0.3% | — |